ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2283

Improving Lactation Knowledge Among Providers Caring for Rheumatology Patients

Brooke Mills1 and Bonnie Bermas 1, 1UT Southwestern Medical Center, Dallas, TX

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: DMARDs, Education, lactation, medical, quality improvement and women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Reproductive Issues In Rheumatic Disorders Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: While the benefits of breastfeeding for both the mother and her infant are well established, available resources regarding medication compatibility with lactation are limited.  Thus, providers may feel ill equipped to encourage breast-feeding amongst patients on anti-rheumatic drugs.  We sought to improve knowledge of the lactation compatibility of medications used to treat rheumatic diseases amongst obstetric and rheumatology providers at an academic medical center that includes a safety net hospital.

Methods: Baseline lactation knowledge was obtained via a multiple-choice survey.  The survey was developed based on a literature review of rheumatology patients’ concerns and knowledge gaps with regards to the lactation process.  Providers were then given a laminated “lactation and rheumatic diseases” information card and asked to take the survey again. Improvement in knowledge was assessed.  The survey will be re-administered three months after the initial survey date to test the sustainability of the intervention.

Results: Twenty-two rheumatology providers were surveyed, including fellows, attendings, nurse practitioners and physician assistants. All of the providers recommended women with rheumatic diseases breastfeed their children.  Twenty-two of 22 providers responded that hydroxychloroquine (HCQ) was compatible with lactation.  In contrast, 10/22 (45%), 8/22 (36%), 10/22 (45%), 5/22 (23%), 7/22 (32%), and 4/22 (18%) of providers were unsure or unaware of the lactation compatibility of prednisone, methotrexate (MTX), leflunomide (LEF), sulfasalazine (SSZ), mycophenolate (MMF), and anti-TNF medications, respectively.  After administration of the information card, 100% of providers correctly answered questions regarding the compatibility of MTX, LEF, SSZ, and MMF with lactation.  Ninety-one percent of providers correctly answered questions regarding the compatibility of TNF therapy with lactation.

Conclusion: There are knowledge gaps among rheumatology providers with regards to medication compatibility with lactation.  Creating a simple structured information card helped to address these deficiencies.  The sustainability of this intervention will be measured.

Knowledge of medication compatibility with lactation improved after administration of the “lactation and rheumatic diseases” information card.

This “Rheumatic Diseases and Lactation” information card was developed to assist providers in determining the compatibility of medications with lactation.


Disclosure: B. Mills, None; B. Bermas, None.

To cite this abstract in AMA style:

Mills B, Bermas B. Improving Lactation Knowledge Among Providers Caring for Rheumatology Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/improving-lactation-knowledge-among-providers-caring-for-rheumatology-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-lactation-knowledge-among-providers-caring-for-rheumatology-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology